Affiliation:
1. The First Affiliated Hospital of Anhui Medical University
Abstract
Abstract
It was reported that liquid-liquid phase separation (LLPS) related genes (LRGs) were involved in the prognosis of a variety of tumors. We aimed to investigate the impact of LRGs on lung adenocarcinoma (LUAD) patients' prognosis, providing further insights for patient treatment and prognosis. TCGA-LUAD, GSE31210 and GSE131907 were applied in this study. Differentially expressed LRGs (DE-LRGs) were identified by intersecting the differentially expressed genes (DEGs) obtained through differential expression analysis with the LRGs acquired from the online database. A total of 17 DE-LRGs were gained by intersecting 5,445 DEGs and LRGs obtained from the online database. Subsequently, TACC3, TPX2, PRC1, FGFR2, ORC1, and PLK4 were identified as prognostic genes for constructing a risk model. The high-risk patients exhibited shorter survival time compared to the low-risk patients in both TCGA-LUAD and GSE31210. The nomogram of pathologic stage and riskScore demonstrated good predictive ability for the 1/3/5-year survival rate of LUAD patients. Next, immune analysis indicated TPX2 exhibited the strongly positive correlation with M0 and M1 macrophages, which displayed the important role of macrophages in the phase separation mechanism. Single cell analysis revealed higher expression levels of prognostic genes in T lymphocytes. We speculated that prognostic genes contributed to tumor development by affecting T-cell activity. Eventually, we verified the differential expression of prognostic genes by testing the expression of clinical samples. In conclusion, TACC3, PRC1, ORC1, and PLK4 were identified to be associated with LLPS on LUAD in this study. It provided further insights into the treatment of LUAD.
Publisher
Research Square Platform LLC
Reference69 articles.
1. Lung cancer;Thai AA;Lancet,2021
2. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart;Travis WD;J Thorac Oncol,2015
3. The biology and management of non-small cell lung cancer;Herbst RS;Nature,2018
4. The EGFR family: not so prototypical receptor tyrosine kinases;Lemmon MA;Cold Spring Harb Perspect Biol,2014
5. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian SL;N Engl J Med,2012